While the exact mechanism of Peyronie's disease (PD) remains an enigma, the pathophysiology of PD is considered to be multifactorial, with interactions of genetic predisposition, trauma, tissue inflammation and aberrant wound healing. A non-systematic review of the existing English language literature pertaining to the use of rodent models in the evaluation of PD was performed using the Medline database. Multiple free-text searches were performed on key words: animal models of PD, transforming growth factor b1 (TGF b1), tunical and/or corporal fibrosis, subtunical injection and penile myofibroblasts. The most frequently reported models of PD can be classified as TGF b1, fibrin and surgical trauma-induced models. In vitro studies using Peyronie's fibroblast culture media have also provided further insights into cellular mechanism of PD. At the present time, the research in PD is hampered by the lack of universally accepted animal model and this is likely attributed to the limited insight into PD mechanisms and the difficulties faced by current animal models to truly represent the complexity and complete spectrum of human disease.
Introduction
Peyronie's disease (PD) is characterised by the presence of a localised fibrotic plaque within the bilaminar penile tunica albuginea layers and is associated with the development of penile pain, curvature and/or deformity, leading ultimately to sexual dysfunction. 1 Recent epidemiological studies have reported the prevalence of PD at 5%; this number is higher in prostate cancer screening populations. 2 Among cohorts of men with PD, increased rates of depression, impaired job performance and increased interpersonal conflicts have all been reported. 3 This relatively common disease was first recognised 4250 years and despite the long history, the exact pathophysiology of this condition is not fully elucidated and the natural history of PD remains controversial. In recent years, innovative basic science research studies have shed lights on the molecular basis of PD. Although spontaneous resolution of penile curvature and Peyronie's plaque is possible, the vast majority of men with PD experience progression of penile deformity. At present, most experts agree that PD arises following (micro)trauma to the erect penis, presumably from buckling forces during sexual activities. However, not every penile trauma leads to development of PD; this aberrant wound healing appears to be more common in certain men with genetic predispositions. 4 Following injury to the erect penis, there is a localised disruption of the penile tunica albuginea and an increase in microvascular permeability with release of various cytokines and growth factors. Published literature highlights the role for cytokines release primarily transforming growth factor b1 (TGF b1) as the predominant profibrotic factor in the development of Peyronie's plaque. 5, 6 TGF b1 is involved in numerous healing processes such as tissue inflammation, induction of angiogenesis, stimulation of matrix formation, production of fibroblast and wound remodelling. However, excess TGF b1 may lead to a disease state with tissue fibrosis and scarring. The ability of TGF b1 to selfinduce production propagates the cycle of fibrosis and scarring, leading to chronic progressive conditions that can obliterate normal tissue architecture. 5 From the initial perivascular inflammatory infiltrate and extravasation of fibrin within the tunica albuginea, there is activation and proliferation of fibroblasts that resulting in persistent fibrin and collagen deposition. In addition, the extracellular matrix becomes disorganized and cellular contraction ensues. 5, 6 The de-differentiation of fibroblasts into myofibroblasts which occurs under the influence of both autocrine and paracrine influences from the various growth factors in the mechanically stressed environment 6 have a pivotal role in tissue repair and the remodelling process of wound healing. Myofibroblasts are not commonly found in the normal tunica albuginea, and were identified in 20% of Peyronie's plaque cell culture. 7 Myofibroblasts contain a-smooth muscle actin, myostatin and well-developed cytoskeletal attachments to the extracellular matrix elements. 6, 8 The continued exposure of myofibroblasts to the tensile stress within the diseased tunica albuginea and subsequent failure to undergo apoptosis contribute to an inappropriate and persistent stimulation of wound healing, a distinctive characteristic of PD. In vivo studies support the role of myostatin in Peyronie's plaque in the animal model and TGF b1 appears to intensify the fibrotic reaction. 9, 10 Myofibroblasts from the PD plaque demonstrate cytogenetic instability, dysfunction of the antitumour p53 gene and tumourigenic potential. 7, [9] [10] [11] When cultured on soft agar, these myofibroblast cell cultures contain osteogenic progenitors that can undergo calcification and/or ossification, a condition observed in advanced cases of PD. 9 The current animal models available for investigation and evaluation of PD are based predominantly on rats for several reasons. First, the anatomy of the rat penis has been extensively described and this model has sufficiently demonstrated similar morphological and functional characteristics to humans. Additionally, they are more economical to purchase, house, maintain and dispose of, compare with larger animals. However, the current animal models in the study of PD are not robust and have been limited by inconsistencies in the timing and duration of penile plaque formation, lack of visible penile plaque, curvature, calcification and/or ossification. The absence of a robust animal model has lead to slow progress in the identification and development of effective therapeutic agent in the treatment of PD. In vitro studies using cell cultures obtained from Peyronie's plaque have, therefore, provided an insight into the cellular mechanism of PD. Newer investigative tools such as proteomic markers, cell-specific immunohistochemistry, western blot analyses and DNA microarray technology have also assisted in the functional and morphologic assessments as well as understanding of the pathophysiology of PD. 12, 13 In the current article, existing English literature pertaining to the use of rodent models for the evaluation of PD is reviewed with primary focus on the development and application of these experimental animal and cell cultures models.
Current animal models of PD
TGF b1 model The TGF b1 model was first proposed by Dr Lue and associates in the late 1990s.
14 TGF b1 is a soluble growth factor of the TGF b superfamily and binds to specific serine/threonine kinase receptors on cell surface, triggering the activation of Smad transcription factors. 15 The profibrotic effects of TGF b are regulated by a complicated signalling network of Smads transcription factors that is involved in cellular proliferation and/or differentiation, an essential system in the pathogenesis of fibrotic disorder. An earlier work by the same group has demonstrated an increased expression of TGF b1 in human PD plaque, 5 leading to the proposed study of TGF b1 in the induction of Peyronie's-like condition in the rat penis. The injection of cytomodulin, a compound with TGF b1-like property, into the tunica tissue of rat penis resulted in substantial chronic cellular infiltration, focal and diffuse elastosis, thickening of tunica albuginea, disorganisation and clumping of collagen bundles, and expression of TGF b1 isoform.
14 These histological features were observed up to 6 weeks, and were similar to that seen in human PD plaque. The expression and activity of the Smad transcription factors in the TGF b pathway were enhanced in PD. 16 The TGF b-induced effects include phosphorylation of Smad2 and Smad3, formation of the complexes of Smad2 and Smad3 with Smad4, while nuclear translocation of these complexes was significantly inhibited by interferon g-induced Smad7 expression. TGF b1 injection model offers distinctive advantages in the study of PD due to its ability to induce chronic inflammation and fibrosis in the tunica tissue over time with only a single administration of TGF b1 compound. This interesting phenomenon is likely attributed to TGF b1 ability to promote its own synthesis by feedback transcriptional stimulation. The ability of TGF b to induce its own production may be the key to the development of the scarring and fibrosis into chronic, progressive condition. 17 Additionally, there was extension of the fibrotic process into the corporal body in the TGF b1-injected rats. However, similar observation was also noted in the saline group, albeit to the lesser degree, perhaps highlighting the potential of TGF b1 extravasation into the corporal tissue at the time of injection.
Review of rodent animal models in Peyronie's disease E Chung et al Bivalacqua et al. 18 reported induction of inducible nitric oxide synthase (iNOS) following the injection of TGF b1 into the tunica albuginea of rat. The iNOS isoform produces nitric oxide (NO) and is overexpressed in Peyronie's plaques. The increase in iNOS expression and activity in the fibroblasts propagate the fibrotic cycle, and in the presence of fibrogenic reactive oxygen species, lead to increase in oxidative stress. 18 NO and its derivative, cyclic guanosine monophosphate, also inhibits collagen synthesis directly. 10 The steady production of NO from iNOS forms peroxynitrite, reduces the levels of profibrotic reactive oxygen species and causes myofibroblast to undergo apoptosis. The importance of iNOS was highlighted in a study by Ferrini et al. 19 who showed long-term inhibition of iNOS activity with increase in fibrosis and plaque formation in the rat penis when a specific inhibitor of iNOS, L-N-(10 iminoethyl) lysine acetate, was given to the rats for 6 weeks following the TGF b1 injection into the tunica albuginea.
TGF b1 has been recognised as the key determinant in the process of fibrosis, but is not the only profibrotic factor responsible for the development of Peyronie's plaque. Cantini et al. 20 demonstrated an overexpression of a second TGF b family member, myostatin, in addition to TGF b1 itself, in the cell cultures of PD plaque and tissues of experimental model of PD. Myostatin is expressed both in vivo and in vitro in myofibroblasts, the cell that have a major role in fibrosis by triggering the proliferation of myofibroblasts, presumable from differentiation of fibroblast cells within the PD plaque. This profibrotic action of myostatin is supported by the finding that in vivo, it elicits a PD-like plaque in the rat tunica albuginea and intensifies the fibrotic process triggered by TGF b1. In contrast, TGF b1 action in the tunica albuginea cell cultures that does not require the presence of myostatin. 9 Although myostatin is profibrotic in the myofibroblasts themselves, it does not stimulate stem cells/myofibroblast lineage differentiation per se. 21 Interestingly, the endogenous presence of high myostatin expression in the normal rat tunical tissue was not associated with fibrosis and attempts to block myostatin expression by the shRNA against myostatin also did not inhibit plaque formation induced by TGF b1. It appeared that TGF b1 is directly responsible for the stimulation of myostatin expression, and in return myostatin upregulates TGF b1 levels. This mutual interaction between TGF b1 and myostatin is paramount to the pathogenesis of fibrotic diseases.
The profibrotic role of TGF b1 in the development of PD has led to several pharmacological applications. First, phosphodiesterase type 5 inhibitors have been utilised and shown to reduced plaque size and oxidative stress by elevating the content of cyclic guanosine monophosphate in penile tissue. 22 The addition of NO generators such as L-arginine (an NOS substrate) to phosphodiesterase type 5 inhibitors prevented the appearance of the PD-like plaque by decreasing the amount of collagen deposition and myofibroblast formation. 23 Another potential target is through the blockade of the Smad pathway as the effects mediated by TGF b1 are regulated by the inhibitory transcription factors Smad6 and Smad7. Interferon upregulates Smad7 activity via the Janus kinase-signal transducer and activates the transcription (JAK/STAT) pathway, leading to inhibition of TGF b1 and apoptosis of myofibroblasts, 24 as demonstrated by the efficacy of interferon a2b in decreasing plaque size and density. 25 The clinical application of antifibrotic pharmacological modulation of endogenous stem cells, particularly with agents belonging to the NO/ cyclic guanosine monophosphate and TGF b1, to block myofibroblast generation is a novel approach and hold great promise as future therapeutic option in the treatment of PD.
One of the major disadvantages of the TGF b1 model relates to the inconsistencies in timing and duration of fibrotic plaque following the subtunical injection of TGF b1 in the rat model. While a single injection of TGF b1 is sufficient to promote fibrotic process, this has not led to the development of penile curvature. Multiple injections of lower doses of a replication-deficient adenoviral construct expressing the full-length TGF b1 proteins were required to induce penile curvature. 26 Despite higher dose and/or repetitive injections of TGF b1 compound, there was a lack or absence of calcification/ossification in rat penis and no significant cartilage formation has been observed. In addition, the penile curvature disappeared spontaneously after 60 days of TGF b1 injection, which could potentially limit the application of TGF b1 model for the study of PD therapy. While at times this Peyronie's plaque was sufficient to induce noticeable penile curvature, it did not lead to the development of ED as claimed by earlier work from Tulane University group. 18 Fibrin model Based on the microtrauma hypothesis, there is an initial perivascular inflammatory cell infiltrate with extravasation of blood proteins released following the fracture of the tunica albuginea. Fibrinogen, a key tissue protein responsible for the wound healing, is converted into fibrin by the action of thrombin, forming a temporary matrix for the support of endothelial cells response. 27 The activities of fibrinogen/fibrin actions are enhanced by binding to growth factors (for example, fibroblast growth factor and vascular endothelial growth factor) and cytokines (interleukins). The mechanism of excessive deposition of fibrin is attributed to the persistence fibrin deposition due to unmasking of Review of rodent animal models in Peyronie's disease E Chung et al fibrinolytic enzymes by other plasma proteins and/ or deficiency of fibrinolytic enzymes or enzyme activity within the abnormal tissue. The persistence of fibrin elicits an acute, and later, a chronic inflammatory response. Subsequent production of profibrotic factors such as TGF b1 and reactive oxygen species induce the development of the fibrotic plaque that epitomises PD.
The initial role of fibrin as the critical determinant in the pathogenesis of PD was first described in 1982. 28 Somers and Dawson 29 reported an excessive collagen deposition, altered elastic fibre configuration and distribution, and extravascular fibrin deposition with accumulation of fibrinogen/fibrin within the plaque tissues in men with PD. The presence of authentic fibrin accumulation was absent in uninvolved tissue from the PD group or normal and/or scarred tunica albuginea from control group. The lack of fibrin clearance could be attributed to the relatively poor vascularisation of the dense connective tissue within the diseased tunica albuginea. Since fibrin is an effective chemoattractant and chemotactic factor, it promotes ingrowth of inflammatory cells, macrophages and fibroblast and induces collagen synthesis by fibroblast, thereby exacerbates the underlying pathological fibrotic process, culminating in plaque formation and potential ossification in the advanced state.
The presence of fibrin was also observed in the nodules of Dupuytren's contracture. The coexistent of PD and Dupuytren's contracture as well as familial tendency between these conditions raise the possibilities of similar chromosomal aberrations in PD and Dupuytren's contracture and is suggestive of a genetic predisposition to pathological fibrosis. 30, 31 The apparently random chromosomal changes associated with PD suggest that karyotype instability may be a common feature of cells within the plaque. It is unclear whether these findings represent multiple pathways for the development of PD or secondary consequences of PD process. Similar study by Mulhall et al.
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also indicated that PD plaque-derived fibroblast has consistent aneusomies even at early stage and that non-plaque tunica-derived cells from men with PD demonstrated chromosomal instability, suggesting that the tunica albuginea of men with PD may be predisposed to undergoing unregulated fibrosis.
Davila et al. 32 reported the use of fibrin in inducing fibrotic plaque in a rat model and found significant fibrotic plaque after 3 weeks following the subtunical fibrin injection. This fibrotic plaque contained high expression of TGF b1 with induction of iNOS, plasminogen activator inhibitor 1 and myofibroblast formation, which resemble those features observed in human PD plaque. The high expression of TGF b1 supports the hypothesis that fibrin deposition after trauma to penis could be the primary event triggering the expression of other profibrotic factors that lead to the development of Peyronie's plaque. The increase in plasminogen activator inhibitor 1 in human PD plaque implies that plasminogen activator inhibitor 1 may have a key role in the inhibition of fibrinolysis and dysregulation of fibrinogen/fibrin pathway. 33 One of the advantageous of this fibrin model is the ability of a single injection of fibrin inducing a fibrotic plaque as early as 3 weeks (shorter than the time required for plaque formation with TGF b1). The fibrotic process in this model is consistent with hallmarks of the TGF b1-induced plaque.
32 While this fibrin model has a faster onset of Peyronie's plaque compare with the TGF b1 model, it can be cumbersome as the fibrin preparation (Tisseel s , Baxter, CA, USA) requires reconstitution of both sealer protein component and thrombin solution, and premature clotting of the solution is a common encounter despite the presence of fibrinolysis inhibitor solution. Additionally, it can be difficult to inject this viscous solution through a small hypodermic needle.
Surgical trauma model
Trauma has a fundamental role in the initiation of the development of PD process. El-Sakka et al. 34 reported prominent inflammatory cellular infiltrates and disorganisation of the collagen bundles in the tunica albuginea of rat penis after 8 weeks following the incision and suture repair of the tunica albuginea of the penis. These histological changes were similar to the reported description of histological features that occurred during the acute phase of PD. In comparison, no abnormal change was detected in the sham surgery/control group where tunica albuginea remained intact. The authors concluded that trauma resulted in an early but transient upregulation of TGF b1 protein expression and histological changes similar to the acute phase but not the overt picture of the chronic phase of PD.
Similar outcomes were also reported by the group from Tulane University 18 who demonstrated that surgical trauma to rat tunica albuginea caused an increase in thickness of the tunica albuginea and fragmentation of the elastic fibres of the tunica tissue. Again, these changes were similar to those observed in the TGF b1 model with the most prominent features of fibrosis ensued after 6 weeks of surgical trauma. In the same article, Bivalacqua et al. 18 reported that needle injection by itself would not cause the histological changes associated with TGF b1 or surgical injury to the tunica albuginea, and a direct incision of the tunica albuginea was required to replicate the surgical trauma model. This observation has been reciprocated in many PD animal models with minimal histological changes observed following the injection of saline in the control group. 1, 14, 32 Review
The surgical model of PD is hampered by the potential role of suture material used in the closure of the incised tunica as an inciting event for an acute inflammatory response leading to plaque formation and providing a nidus for a later, chronic inflammatory reaction.
Genetic/spontaneous model
Innovative work from researchers in Italy reported the first example of naturally occurring model for PD using tight skin (Tsk), C57B1/6J subline mice that produce characteristic fibrous plaque, penile curvature and areas of chondroid metaplasia with heterotopic ossification similar to human disease. 35 The authors reported an upregulation of hypoxicinducible factor-1 (HIF-1) leading to an increased downstream expression of HIF-1 target genes such as TGF b and iNOS, resulting in the collagen deposition in Tsk penises. Tsk mutation is characterised by a tandem duplication of fibrillin-1 gene associated with fibrotic and/or sclerotic lesions. Fibrillin is thought to be involved in the regulation of extracellular matrix and the control of bioavailability of various cytokine (including TGF b).
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HIF-1 expression is activated in a hypoxic microenvironment and led to an increased expression of iNOS, possibly a compensatory mechanism that partially counteracts collagen deposition and inhibits fibroblasts differentiation into myofibroblasts through NO synthesis. 10 The overexpression of HIF-1 and dysregulation in the fibrillin function are likely to result in the development of PD in Tsk mice.
While this is animal model of spontaneous PD could facilitate study of many similar aspects of human PD, there are several limitations in the Tsk model. First, there was no disease progression observed in the Tsk mice penis after 12 months of age, suggesting that this genetic model is perhaps a limiting event. There was also lack of information pertaining to possible changes in penile smooth muscle from the systemic action of HIF-1 genetic alteration leading to excessive cavernosal fibrotic changes. In addition, widespread fibrotic process involving many organs was observed, illustrating a systemic sclerotic disease process rather than local penile tunica change.
Newer models: cell cultures models from Peyronie's plaque Cell cultures from human PD plaque and normal tunica albuginea have provided valuable information with regard to knowledge on the cellular and molecular basis of PD that is not readily available through the animal models. De Young et al. 12 showed that primary cell cultures from PD plaque displayed overexpression of several proteins that are established components of fibrosis and wound healing. Although the role of myofibroblast in the development of PD plaque was first described in 1982, 28 recent studies have shown the importance of this differentiation of fibroblasts and tunica stem cells in the pathophysiology of PD. [6] [7] [8] [9] [10] [11] In a mechanically stressed environment and presence of various tissue growth factors and cytokines, myofibroblast cells demonstrated cytogenetic instability, excess production of fibrogenic cytokines and other functional alterations. 7, 9, 11 The continued exposure of these cells to tensile forces and the underlying defective apoptotic mechanism resulted in an inappropriate and persistent stimulation of the wound healing process.
Several studies have been conducted in the attempt to minimise the production and proliferation of myofibroblasts. Vernet et al. 10 showed that following the induction of iNOS with a cytokine cocktail and an NO donor, S-nitroso-N-acetyl penicillamine, there was a reduction in the total number of myofibroblast cells and the number of a-smooth muscle cells. On the other hand, Del Carlo et al. 37 focussed on the role of interleukin-1b on matrix metalloproteinases. This article highlighted the role of matrix metalloproteinases in collagen degradation, and TGF b-induced tissue inhibitors of metalloproteinases leading to interference in the breakdown of collagen fibres deposited in excess during the development of the PD plaque. This article underlined the importance of the matrix metalloproteinase/tissue inhibitors of metalloproteinase/plasminogen activator inhibitor 1 system and the interplay between the collagenolytic and fibrinolytic pathways and their inhibitors in the pathogenesis of PD.
Recent genetic profiling studies have provided additional information to define the molecular basis of PD plaque. Magee et al. 13 reported upregulation of PTN (OSF-1) gene, a secreted heparin-binding protein that is thought to stimulate mitogenic growth of fibroblasts and osteoblast recruitment; and MCP-1 gene, which has a critical role in the inflammatory response and ossification, while downregulation of Smad7 gene, a key signal-transducing protein responsible in the transcription of JAK/STAT pathway. This preliminary study addresses the role of genetic alteration that may explain the plaque variability in PD men and allows for further investigation in novel potential therapeutic targets for the treatment of PD.
Conclusions
While the exact mechanism of PD is not fully elucidated, the pathophysiology of PD is considered to be multifactorial, with interactions of genetic predisposition, trauma, tissue inflammation and aberrant wound healing. The development of a Peyronie's plaque is thought to occur following the Review of rodent animal models in Peyronie's disease E Chung et al trauma during sexual activity that leads to the accumulation of fibrin, expression of profibrotic factors (for example, production of TGF b1), production of reactive oxygen species and induction of myofibroblasts, leading to increased deposition and disorganisation of collagen fibres within the tunica albuginea, and in some cases calcification and ossification.
At the present time, the research in PD (Table 1) is hampered by the lack of universally accepted animal model and this is likely attributed to the limited insight into PD mechanisms and the difficulties faced by current animal models to truly represent the complexity and complete spectrum of human disease. While the intratunical injections of TGF b1 and fibrin have led to a more robust model of Peyronie's plaque, they are limited by the inconsistencies in the formation of PD plaque, penile curvature and calcification/ossification, as well as commonly accompanied by extension of fibrosis into adjacent corporal tissue, a result of technical difficulty in limiting the injection exclusively within the tunica albuginea. Newer investigative techniques such as the use of stem cells and selective induction of anti-inflammatory/fibrotic agents in both animal model and cell culture media have the potential to improve our current understanding in PD mechanisms, hold promising experimental studies and develop novel long-term pharmacological approaches to treat PD. Abbreviations: PD, Peyronie's disease; TGF b1, transforming growth factor b1.
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